Gamma-aminobutyric acid receptor agonists, aquaporin-4, and neuromyelitis optica: a potential link

Medical Hypotheses
Sven JariusB Wildemann

Abstract

Neuromyelitis optica (NMO; also termed Devic's disease) is a severely disabling autoimmune disorder of the central nervous system (CNS), which predominantly affects the optic nerves and spinal cord. In up to 80% of cases, NMO is associated with antibodies to aquaporin-4 (AQP4-IgG), the most abundant water channel in the CNS. AQP4-IgG have been demonstrated to be directly pathogenic. Gamma-aminobutyric acid A receptor (GABAAR) agonists are frequently used in patients with NMO, e.g., for symptomatic treatment of spasticity or epilepsy or for non-NMO-related indications such as treatment of insomnia. However, GABAAR signaling has recently been shown to strongly promote AQP4 expression. This is of potential clinical importance since any increase in AQP4 membrane expression during acute NMO attacks may enhance the complement-mediated humoral immune reaction against AQP4-expressing cells characteristic for NMO and, thus, result in more severe CNS damage. We therefore hypothesize that GABAAR agonist-induced AQP4 upregulation may be a potential risk factor in NMO. This would also include a potential role for (GABAAR-enhanced) damage to the subependymal zone neural stem cells, the major source of both glial cells and neuroblasts in the ...Continue Reading

References

May 30, 2003·Journal of Neuroscience Research·Feng GuJunya Tanaka
Jan 29, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Allison M Quick, Marilyn J Cipolla
Aug 10, 2005·The Journal of Experimental Medicine·Vanda A LennonShannon R Hinson
Jul 25, 2007·Neuropathology : Official Journal of the Japanese Society of Neuropathology·Jun-ichi SatohHidehiko Konno
Oct 8, 2008·Pediatrics·Timothy E LotzeJill V Hunter
Oct 24, 2008·Journal of the Neurological Sciences·Katsuichi MiyamotoSusumu Kusunoki
Dec 17, 2009·BMJ : British Medical Journal·Reinhard ReussUwe K Zettl
May 12, 2010·Neurology·N SuzukiY Itoyama
Jul 20, 2010·Nature Reviews. Neurology·Sven Jarius, Brigitte Wildemann
Nov 4, 2010·Glia·Moonhee LeePatrick L McGeer
Dec 22, 2010·Neurology·Joseph S JeretKazuo Fujihara
Apr 7, 2011·Acta Neuropathologica·Maria PohlMonika Bradl
Dec 1, 2011·Proceedings of the National Academy of Sciences of the United States of America·Shannon R HinsonVanda A Lennon
Dec 21, 2011·Multiple Sclerosis : Clinical and Laboratory Research·Piyush BankerYvonne W Lui
May 15, 2012·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·C A McGrawM S Robbins
Sep 20, 2012·Internal Medicine·Shoko DeguchiKoji Abe
Sep 25, 2012·Epilepsy Research·Hitoshi NakanoTetsuro Konishi
Jan 17, 2013·Journal of Neuroinflammation·Sven Jarius, Brigitte Wildemann
Jul 10, 2013·Journal of Neurology·Yára Dadalti FragosoFabio Siquineli
Nov 5, 2013·Medical Hypotheses·S Jarius, B Wildemann
Mar 29, 2014·Clinical and Experimental Immunology·S JariusF Paul
Jun 21, 2015·Neurology·Dean M WingerchukUNKNOWN International Panel for NMO Diagnosis

❮ Previous
Next ❯

Citations

Sep 6, 2021·Journal of Neurology·Hesham AbboudUNKNOWN On-behalf of the Guthy-Jackson Foundation NMO International Clinical Consortium

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.